Facile Therapeutics
Allan Wagman has a vast experience in the pharmaceutical industry, with a background in Chemistry. Currently, Allan is serving as the Vice President at Rain Oncology, overseeing various aspects of Technical Operations and Research Medicinal Chemistry. Prior to this, Allan held positions at Sagimet Biosciences, Blanca Pharmaceuticals, LLC, Achaogen, Inc, Novartis, and Chiron Corporation, where Allan demonstrated leadership in drug discovery and development projects. Allan holds a BS in Organic Chemistry from Carnegie Mellon University, a PhD in Organic Chemistry from The University of Texas at Austin, and a Post Doc in Organic Chemistry from the University of North Carolina at Chapel Hill.
This person is not in any offices
Facile Therapeutics
Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.